FIELD: chemistry.
SUBSTANCE: invention refers to N, S-substituted isothiourea derivatives of the general formula (1) in the form of salts with pharmacologically acceptable acids as a NOS-inhibitory and vasopressor agent wherein: n=1, 3, i.e. an acyl substitute represents cyclobutanoyl or cyclohexanoyl; R represents an alkyl group: C2H5, i-C3H7; HX represents a pharmacologically acceptable inorganic or organic acid: HCl, HBr, HI, hydrogen methyl sulphate, oxalic, succinic acids, etc.
EFFECT: extending the range of products of the vasopressor action.
6 cl, 7 tbl, 10 ex
Title | Year | Author | Number |
---|---|---|---|
VASOCONSTRICTOR | 2011 |
|
RU2475479C1 |
ANTIHYPOTENSION MEDICATION | 2007 |
|
RU2353614C1 |
ANTIHYPOTONIC AGENT | 2011 |
|
RU2506082C2 |
ANTIANTIHYPERTENSIVE | 2007 |
|
RU2338538C1 |
METHOD FOR PREMEDICATION IN PATIENTS WITH A LOCAL KIDNEY CANCER WITH ARTERIAL HYPERTENSION CONTROLLED BY ANGIOTENSINE TRANSFORMING ENZYME INHIBITORS | 2018 |
|
RU2681496C1 |
AGENT EFFECTING ON ARTERIAL PRESSURE | 1997 |
|
RU2187309C2 |
METHOD OF SHOCK TREATMENT | 1989 |
|
RU2012333C1 |
INFUSION SOLUTION | 2019 |
|
RU2708389C1 |
MEDICINAL ANTISHOCK AGENT | 1996 |
|
RU2142796C1 |
METHOD FOR EVALUATING CONDITION OF CARDIOVASCULAR SYSTEM REGULATION | 2002 |
|
RU2214160C1 |
Authors
Dates
2015-06-10—Published
2013-11-29—Filed